CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 506 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02534675
NCT02534675N/ACompleted

An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Malignancies and Poor Prognosis

University of California, San Diego·observational·Posted Aug 28, 2015·Updated Mar 29, 2023

In Brief

An observational study for Cancer. Completed, enrolled 506 participants across 2 sites.

Detailed Summary

The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information from the patient's medical record regarding the tests and treatments they have received, or will receive, for their cancer will be collected. Genomic testing on tissue from the primary tumor or metastases will be used to match therapy recommendations. Patients in which there is no appropriate matched therapy will receive systemic chemotherapy according to their treating physician's discretion. This information will be used to describe whether or not patients respond better when their physicians choose to treat them according to the genetic makeup of their tumor.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
CollaboratorsFoundation Medicine

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 28, 2015
Enrollment StartFeb 1, 2015
Primary CompletionDec 17, 2020
Study CompletionDec 1, 2022
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 10.8 years ago